Genetic heterogeneity during breast cancer progression in young patientsKanako Hagio(Hokkaido University Hospital), Hiroko Yamashita(Nagoya City University)The BreastOctober 28, 202110.1016/j.breast.2021.10.011Cited by 9SaveCiteExport RISWatch citationsRelated PapersPhosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer|Breast Cancer Research|2005|103